TERT and uterine cervix carcinoma in situ: TERT, which encodes the catalytic subunit of the telomerase complex hTERT and have been found to be amplified or upregulated in more than 90% of squamous cell cervical carcinomas and 40% of CIN III lesions [43], had a fold change of 1.45, just below the selected cut-off (Figure 2).